多参数超声用于前列腺癌检测与定位:B型超声、剪切波弹性成像和对比增强超声与根治性前列腺切除标本的相关性
研究纳入2017年5月至7月间50例活检证实前列腺癌并接受根治性前列腺切除术的男性,术前行多参数超声(B型超声、剪切波弹性成像、对比增强超声及定量软件组合),由3名读者独立评估12个解剖感兴趣区。以根治性前列腺切除组织病理为参考标准,多参数超声对临床显著前列腺癌的感兴趣区敏感度为74%(95%CI 67-80),高于B型超声的55%(95%CI 47-63)、剪切波弹性成像的55%(95%CI 47-63)和对比增强超声的59%(95%CI 51-67)。
要点
- 多参数超声(Likert≥3)对临床显著前列腺癌的感兴趣区敏感度为74%(95%CI 67-80)。
- B型超声、剪切波弹性成像、对比增强超声的敏感度分别为55%、55%、59%。
- 多参数超声在Likert阈值及所有临床显著前列腺癌定义下敏感度均显著更高(均p<0.05)。
核心结论
- 多参数超声(B型超声、剪切波弹性成像和带参数图的对比增强超声)相比单一超声模态改善了临床显著前列腺癌的定位和指数病灶检测,获得良好敏感度。
研究设计与样本
- 2017年5月至2017年7月,50例活检证实前列腺癌的男性在1个中心于根治性前列腺切除术前接受多参数超声。
- 3名读者独立评估12个解剖感兴趣区,对每种单独超声模态及多参数超声采用5点Likert量表评估临床显著前列腺癌可能性。
- 采用逻辑线性混合模型估计临床显著前列腺癌定位的诊断性能,以Likert评分≥3和≥4为阈值;为检测指数病灶,读者选择2个最可疑的感兴趣区。
主要发现
- 最终分析纳入48例男性。
- 多参数超声(Likert≥3)对临床显著前列腺癌的感兴趣区敏感度为74%(95%CI 67-80),B型超声为55%(95%CI 47-63),剪切波弹性成像为55%(95%CI 47-63),对比增强超声为59%(95%CI 51-67)。
- 多参数超声在Likert阈值和所有不同的临床显著前列腺癌定义下敏感度均显著更高(均p<0.05)。
- 多参数超声改善了指数病灶前列腺癌的检测。
关键数值与推荐
- 临床显著前列腺癌定义为任何Gleason评分3+4=7或更高、肿瘤体积≥0.5 ml、前列腺外侵犯或分期pN1的肿瘤。
- 诊断性能阈值采用Likert评分≥3和≥4。
- 多参数超声(Likert≥3)的感兴趣区敏感度为74%(95%CI 67-80)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Similar to multiparametric magnetic resonance imaging, multiparametric ultrasound represents a promising approach to prostate cancer imaging. We determined the diagnostic performance of B-mode, shear wave elastography and contrast enhanced ultrasound with quantification software as well as the combination, multiparametric ultrasound, for clinically significant prostate cancer localization using radical prostatectomy histopathology as the reference standard. MATERIALS AND METHODS: From May 2017 to July 2017, 50 men with biopsy proven prostate cancer underwent multiparametric ultrasound before radical prostatectomy at 1 center. Three readers independently evaluated 12 anatomical regions of interest for the likelihood of clinically significant prostate cancer on a 5-point Likert scale for all separate ultrasound modalities and multiparametric ultrasound. A logistic linear mixed model was used to estimate diagnostic performance for the localization of clinically significant prostate cancer (any tumor with Gleason score 3 + 4 = 7 or greater, tumor volume 0.5 ml or greater, extraprostatic extension or stage pN1) using a Likert score of 3 or greater and 4 or greater as the threshold. To detect the index lesion the readers selected the 2 most suspicious regions of interest. RESULTS: A total of 48 men were included in the final analysis. The region of interest specific sensitivity of multiparametric ultrasound (Likert 3 or greater) for clinically significant prostate cancer was 74% (95% CI 67-80) compared to 55% (95% CI 47-63), 55% (95% CI 47-63) and 59% (95% CI 51-67) for B-mode, shear wave elastography and contrast enhanced ultrasound, respectively. Multiparametric ultrasound sensitivity was significantly higher for Likert thresholds and all different clinically significant prostate cancer definitions (all p <0.05). Multiparametric ultrasound improved the detection of index lesion prostate cancer. CONCLUSIONS: Multiparametric ultrasound of the prostate, consisting of B-mode, shear wave elastography and contrast enhanced ultrasound with parametric maps, improved localization and index lesion detection of clinically significant prostate cancer compared to single ultrasound modalities, yielding good sensitivity.
引用
- Mannaerts CK, Wildeboer RR, Remmers S, et al. Multiparametric Ultrasound for Prostate Cancer Detection and Localization: Correlation of B-mode, Shear Wave Elastography and Contrast Enhanced Ultrasound with Radical Prostatectomy Specimens. J Urol. 2019. PMID: 31246546. doi:10.1097/JU.0000000000000415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。